WallStreetZenWallStreetZen

NASDAQ: SDGR
Schrodinger Inc Stock

$24.04-0.77 (-3.1%)
Updated Apr 24, 2024
SDGR Price
$24.04
Fair Value Price
$27.85
Market Cap
$1.74B
52 Week Low
$20.76
52 Week High
$59.24
P/E
42.18x
P/B
3.17x
P/S
11.86x
PEG
0.82x
Dividend Yield
N/A
Revenue
$216.67M
Earnings
$40.72M
Gross Margin
64.9%
Operating Margin
19.81%
Profit Margin
18.8%
Debt to Equity
0.46
Operating Cash Flow
-$137M
Beta
1.06
Next Earnings
May 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SDGR Overview

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SDGR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SDGR ($24.04) is undervalued by 13.68% relative to our estimate of its Fair Value price of $27.85 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SDGR ($24.04) is not significantly undervalued (13.68%) relative to our estimate of its Fair Value price of $27.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SDGR ($24.04) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SDGR due diligence checks available for Premium users.

Be the first to know about important SDGR news, forecast changes, insider trades & much more!

SDGR News

Valuation

SDGR fair value

Fair Value of SDGR stock based on Discounted Cash Flow (DCF)
Price
$24.04
Fair Value
$27.85
Undervalued by
13.68%
SDGR ($24.04) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SDGR ($24.04) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SDGR ($24.04) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SDGR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
42.18x
Industry
72.14x
Market
41.27x
SDGR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SDGR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

SDGR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.17x
Industry
3.39x
SDGR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SDGR price to earnings growth (PEG)

For valuing profitable companies with growth potential
SDGR is good value based... subscribe to Premium to read more.
PEG Value Valuation

SDGR's financial health

Profit margin

Revenue
$74.1M
Net Income
-$30.7M
Profit Margin
-41.4%
SDGR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SDGR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$803.0M
Liabilities
$254.4M
Debt to equity
0.46
SDGR's short-term assets ($567.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SDGR's short-term assets ($567.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SDGR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SDGR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$37.3M
Investing
-$59.6M
Financing
$2.3M
SDGR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SDGR vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
SDGR$1.74B-3.10%42.18x3.17x
BTSG$1.85B+0.75%-8.23x3.16x
AGTI$1.37B+0.60%-72.14x1.46x
PRVA$2.15B-3.35%90.85x3.84x
OMCL$1.26B-3.52%-60.96x1.06x

Schrodinger Stock FAQ

What is Schrodinger's quote symbol?

(NASDAQ: SDGR) Schrodinger trades on the NASDAQ under the ticker symbol SDGR. Schrodinger stock quotes can also be displayed as NASDAQ: SDGR.

If you're new to stock investing, here's how to buy Schrodinger stock.

What is the 52 week high and low for Schrodinger (NASDAQ: SDGR)?

(NASDAQ: SDGR) Schrodinger's 52-week high was $59.24, and its 52-week low was $20.76. It is currently -59.42% from its 52-week high and 15.8% from its 52-week low.

How much is Schrodinger stock worth today?

(NASDAQ: SDGR) Schrodinger currently has 72,310,612 outstanding shares. With Schrodinger stock trading at $24.04 per share, the total value of Schrodinger stock (market capitalization) is $1.74B.

Schrodinger stock was originally listed at a price of $28.64 in Feb 6, 2020. If you had invested in Schrodinger stock at $28.64, your return over the last 4 years would have been -16.06%, for an annualized return of -4.28% (not including any dividends or dividend reinvestments).

How much is Schrodinger's stock price per share?

(NASDAQ: SDGR) Schrodinger stock price per share is $24.04 today (as of Apr 24, 2024).

What is Schrodinger's Market Cap?

(NASDAQ: SDGR) Schrodinger's market cap is $1.74B, as of Apr 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Schrodinger's market cap is calculated by multiplying SDGR's current stock price of $24.04 by SDGR's total outstanding shares of 72,310,612.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.